According to the Swiss media outlet horizont, the Swiss Competition Commission has banned commercial advertising for e-cigarettes and nicotine products aimed at minors from July 1st. This includes the popular product Snus (a form of oral tobacco). This decision comes ahead of the new tobacco product act, which is scheduled to take effect at the beginning of 2024.
According to reports, in May of this year, the Swiss Competition Commission decided at a plenary session to expand the relevant provisions to include e-cigarettes and oral nicotine products.
Guideline D.7 now explicitly prohibits all commercial advertising of tobacco products, e-cigarettes, nicotine products and alcoholic beverages aimed specifically at minors under 18 years of age. This includes advertising in areas where youth congregate, youth-oriented media, sports and events primarily attended by minors, as well as promotional campaigns and tours.
The Fair Competition Commission expects market participants to comply with the new regulations in order to protect minors as soon as possible," the commission stated on Tuesday evening.
According to the international study "Health Behavior in School-aged Children" (HBSC), e-cigarette consumption is most common among 15-year-old teenagers in Switzerland, accounting for 21%. The trendy snus accounts for 7.3%. Although the percentages may seem small, they have doubled compared to 2018.
Reference:
The Fairness Commission expands youth protection to include e-cigarettes and snuff.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
